Nervous about titrating up but symptoms have been at a minimum so Ill be fine
These research citations provide a comprehensive overview of the latest clinical evidence and scientific insights into the management of ulcerative colitis, including the efficacy, safety, and potential interactions of emerging therapeutic agents such as semaglutide
If your primary concern involves gastritis, leaky gut, intestinal inflammation, or other digestive issues, oral BPC-157 makes theoretical sense and receives the most favorable user reports
Clinical data suggests oral tirzepatide achieves approximately 15% bioavailability compared to injected doses, meaning higher oral doses are needed to match injectable concentrations
36 This allows for: Monitoring for side effects, especially GI issues like nausea, vomiting, or diarrhea